Abstract

Background: The fruit of Rosa abyssinica Lindley (Rosaceae) is claimed to alleviate depression in folkloric Ethiopian medicine. Nevertheless, the antidepressant-like effect has not been assessed in rodent models of depression. Methods: The test animals were randomly selected and divided into five groups (n = 8). Group I and II received 2% Tween 80 and the standard drug imipramine (30 mg/kg) respectively while Groups III to V received increasing doses of the extracts and duration of immobility at three dose levels of the crude extract and (100, 200, and 400 mg/kg) was the parameter determined to assess the antidepressant-like activity of R. abyssinica in tail suspension test (TST) and forced swimming test (FST). The locomotor activity was also evaluated in terms of number of square crossings using the open field test (OFT) in order to rule out possible psycho-stimulant activity. Results: The crude extract at the doses of 200 mg/kg and 400 mg/kg significantly reduced the time of immobility in the TST and FST. The aqueous fraction at 200 mg/kg displayed a significant reduction of 38% in the duration of immobility in TST which was superior to the effect of imipramine. The methanol fraction displayed a significant reduction in the duration of immobility of 33.93% only at 200 mg/kg. The ethyl acetate fraction was devoid of activity. No significant change in locomotor activity was detected in all the doses of the crude extract and imipramine in OFT. Conclusion: The results of this study suggest that this plant possesses an appreciable antidepressant-like activity.

Highlights

  • Depression is a chronic mental disorder that causes changes in mood, thoughts, behavior and physical health [1]

  • According to the World Health Organization (WHO) unipolar depression is one of the leading causes of disability- adjusted life year (DALY) and approximately 350 million people worldwide are said to suffer from this mental disorder [2]

  • Acute toxicity study The acute toxicity study revealed the non-toxic nature of the 80%

Read more

Summary

Introduction

Depression is a chronic mental disorder that causes changes in mood, thoughts, behavior and physical health [1]. According to the World Health Organization (WHO) unipolar depression is one of the leading causes of disability- adjusted life year (DALY) and approximately 350 million people worldwide are said to suffer from this mental disorder [2]. Depression pharmacotherapy focused on the brain monoamine neurotransmitters level following the serendipitous discovery of imipramine and iproniazid as antidepressants [4,5]. Diverse theories have been proposed to elucidate the pathophysiology of depressive disorders, some that have gained recognition are: abnormalities in the areas of the brain that are responsible for the regulation of mood, reward response and executive functions [5,6]. The antidepressant-like effect has not been assessed in rodent models of depression

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call